Long-term effect of bezafibrate on parameters of hepatic fibrosis in primary biliary cirrhosis

被引:30
作者
Ohmoto, Kenji [1 ]
Yoshioka, Naoko [1 ]
Yamamoto, Shinichiro [1 ]
机构
[1] Kawasaki Med Sch, Dept Med, Div Hepatol, Kurashiki, Okayama 7010192, Japan
关键词
Hyaluronic Acid; Primary Biliary Cirrhosis; Ursodeoxycholic Acid; Live Donor Liver Transplantation; Familial Hypercholesterolemia;
D O I
10.1007/s00535-006-1778-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:502 / 503
页数:3
相关论文
共 5 条
[1]   Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model [J].
Forns, X ;
Ampurdanès, S ;
Llovet, JM ;
Aponte, J ;
Quintó, L ;
Martínez-Bauer, E ;
Bruguera, M ;
Sánchez-Tapias, JM ;
Rodés, J .
HEPATOLOGY, 2002, 36 (04) :986-992
[2]   Long-term fibrate treatment for PBC [J].
Nakamuta, M ;
Enjoji, M ;
Kotoh, K ;
Shimohashi, N ;
Tanabe, Y .
JOURNAL OF GASTROENTEROLOGY, 2005, 40 (05) :546-547
[3]   Effect of bezafibrate in primary biliary cirrhosis: a pilot study [J].
Ohmoto, K ;
Mitsui, Y ;
Yamamoto, S .
LIVER, 2001, 21 (03) :223-224
[4]   A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C [J].
Wai, CT ;
Greenson, JK ;
Fontana, RJ ;
Kalbfleisch, JD ;
Marrero, JA ;
Conjeevaram, HS ;
Lok, ASF .
HEPATOLOGY, 2003, 38 (02) :518-526
[5]   DETECTION OF HEPATIC FIBROGENESIS - A REVIEW OF AVAILABLE TECHNIQUES [J].
WU, JA .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1995, 30 (09) :817-825